These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 16433455

  • 1. [The quest for an HIV vaccine].
    Girard MP.
    Bull Acad Natl Med; 2005 May; 189(5):831-44; discussion 844. PubMed ID: 16433455
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HIV vaccine development: a subtype E-specific strategy.
    Brown AE, McNeil JG.
    Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):377-82. PubMed ID: 9886132
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
    Belshe RB, Stevens C, Gorse GJ, Buchbinder S, Weinhold K, Sheppard H, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege AM, Harro C, Corey L, Keefer M, Mulligan M, Wright P, Celum C, Judson F, Mayer K, McKirnan D, Marmor M, Woody G, National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET).
    J Infect Dis; 2001 May 01; 183(9):1343-52. PubMed ID: 11294665
    [Abstract] [Full Text] [Related]

  • 8. An HIV vaccine: how and when?
    Esparza J.
    Bull World Health Organ; 2001 May 01; 79(12):1133-7. PubMed ID: 11799445
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HIV vaccines: new frontiers in vaccine development.
    Duerr A, Wasserheit JN, Corey L.
    Clin Infect Dis; 2006 Aug 15; 43(4):500-11. PubMed ID: 16838241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. AIDS vaccine development: the long and winding road.
    Garber DA, Feinberg MB.
    AIDS Rev; 2003 Aug 15; 5(3):131-9. PubMed ID: 14598562
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.
    Francis DP, Gregory T, McElrath MJ, Belshe RB, Gorse GJ, Migasena S, Kitayaporn D, Pitisuttitham P, Matthews T, Schwartz DH, Berman PW.
    AIDS Res Hum Retroviruses; 1998 Oct 15; 14 Suppl 3():S325-31. PubMed ID: 9814961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.